Eagle Pharmaceuticals Inc... (EGRX)
1.00
0.00 (0.00%)
At close: Mar 27, 2025, 10:53 AM
1.00
0.00%
Pre-market: Mar 27, 2025, 10:53 AM EDT
Eagle Pharmaceuticals Income Statement
| Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 316.61M | 171.55M | 187.8M | 195.89M | 213.31M | 236.71M | 189.48M | 66.23M | 19.1M | 13.68M | 2.54M |
| Cost of Revenue | 94.94M | 42.18M | 45.47M | 60.9M | 61.92M | 57.19M | 55.31M | 15.65M | 11.71M | 7.38M | 3.17M |
| Gross Profit | 221.67M | 129.37M | 142.34M | 135M | 151.4M | 179.52M | 134.18M | 50.58M | 7.38M | 6.3M | -627K |
| Operating Income | 80.96M | -2.91M | 25.25M | 21.82M | 36.62M | 73.99M | 53.35M | 2.56M | -18.76M | -8.46M | -19.83M |
| Interest Income | 271K | 560K | 562K | 2.17M | 158K | 91K | 84K | 25K | 31K | 3.21K | 34K |
| Pretax Income | 61.43M | -4.55M | 22.68M | 22M | 34.04M | 72.94M | 53.43M | 2.57M | -19.27M | -6.95M | -20.16M |
| Net Income | 35.64M | -8.63M | 11.99M | 14.31M | 31.9M | 51.94M | 81.45M | 2.57M | -17.98M | -6.05M | -19.38M |
| Selling & General & Admin | 106.63M | 75.32M | 78.6M | 76.37M | 60.51M | 71.42M | 52.31M | 20.16M | 9.33M | 4.96M | 6.4M |
| Research & Development | 34.09M | 51.27M | 30.79M | 36.81M | 44.42M | 32.61M | 30.26M | 27.86M | 16.82M | 9.8M | 12.8M |
| Other Expenses | n/a | -6.24M | -8.26M | 700K | 52.23M | 35.22M | 32.57M | n/a | 35K | 3.2K | 12K |
| Operating Expenses | 140.71M | 126.6M | 109.38M | 113.18M | 104.93M | 104.02M | 82.58M | 48.02M | 26.14M | 14.75M | 19.2M |
| Interest Expense | 4.04M | 1.64M | 2.58M | 2.69M | 2.74M | 1.14M | 8K | 11K | 8K | 1.4M | 309K |
| Selling & Marketing Expenses | 8.5M | 8.5M | 2.7M | 2.4M | 3.3M | -1.65M | 14.78M | 4.75M | 4.3M | n/a | n/a |
| Cost & Expenses | 235.65M | 168.78M | 154.85M | 174.08M | 166.84M | 161.21M | 137.88M | 63.67M | 37.86M | 22.13M | 22.37M |
| Income Tax | 25.79M | 4.08M | 10.69M | 7.68M | 2.13M | 21M | -28.03M | 3K | -1.29M | -898.7K | -781K |
| Shares Outstanding (Basic) | 12.93M | 13.05M | 13.48M | 13.75M | 14.77M | 15.1M | 15.53M | 15.25M | 9.96M | 10.57M | 10.57M |
| Shares Outstanding (Diluted) | 13.07M | 13.05M | 13.77M | 14.14M | 15.28M | 15.91M | 16.43M | 16.25M | 9.96M | 10.57M | 10.57M |
| EPS (Basic) | 2.76 | -0.66 | 0.89 | 1.04 | 2.16 | 3.44 | 5.24 | 0.17 | -1.81 | -0.57 | -1.83 |
| EPS (Diluted) | 2.73 | -0.66 | 0.87 | 1.01 | 2.09 | 3.27 | 4.96 | 0.16 | -1.81 | -0.57 | -1.83 |
| EBITDA | 77.5M | 2.77M | 30.02M | 28.18M | 40.44M | 77.83M | 55.02M | 2.7M | -18.76M | -8.41M | -19.61M |
| Depreciation & Amortization | 12.02M | 4.81M | 4.77M | 4.65M | 3.67M | 3.75M | 1.59M | 112K | 104K | 134.99K | 240K |